Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A CpG-Ficoll Nanoparticle Adjuvant for Anthrax Protective Antigen Enhances Immunogenicity and Provides Single-Immunization Protection against Inhaled Anthrax in Monkeys
Melissa A. Kachura, Colin Hickle, Sariah Kell, et al.
The Journal of Immunology (2015) Vol. 196, Iss. 1, pp. 284-297
Open Access | Times Cited: 26

Showing 1-25 of 26 citing articles:

Development of the CpG Adjuvant 1018: A Case Study
John D. Campbell
Methods in molecular biology (2016), pp. 15-27
Closed Access | Times Cited: 173
Advances and Opportunities in Nanoparticle‐ and Nanomaterial‐Based Vaccines against Bacterial Infections
Leon C. W. Lin, Saborni Chattopadhyay, Jung‐Chen Lin, et al.
Advanced Healthcare Materials (2018) Vol. 7, Iss. 13
Closed Access | Times Cited: 97
Trimethyl Chitosan Nanoparticles Encapsulated Protective Antigen Protects the Mice Against Anthrax
Anshu Malik, Manish Gupta, Rajesh Mani, et al.
Frontiers in Immunology (2018) Vol. 9
Open Access | Times Cited: 68
Antimicrobial resistance in livestock: advances and alternatives to antibiotics
Ronald R. Marquardt, Suzhen Li
Animal Frontiers (2018) Vol. 8, Iss. 2, pp. 30-37
Open Access | Times Cited: 57
Current Status and Trends in Prophylaxis and Management of Anthrax Disease
Vladimir Savransky, Б. И. Ионин, Joshua J. Reece
Pathogens (2020) Vol. 9, Iss. 5, pp. 370-370
Open Access | Times Cited: 48
Prophylactic vaccine delivery systems against epidemic infectious diseases
Chao Pan, Hua Yue, Li Zhu, et al.
Advanced Drug Delivery Reviews (2021) Vol. 176, pp. 113867-113867
Open Access | Times Cited: 31
Engineered nanomaterials and human health: Part 2. Applications and nanotoxicology (IUPAC Technical Report)
Vladimir Gubala, Linda J. Johnston, Harald F. Krug, et al.
Pure and Applied Chemistry (2018) Vol. 90, Iss. 8, pp. 1325-1356
Open Access | Times Cited: 35
Future of humanChlamydiavaccine: potential of self-adjuvanting biodegradable nanoparticles as safe vaccine delivery vehicles
Rajnish Sahu, Richa Verma, Saurabh Dixit, et al.
Expert Review of Vaccines (2018) Vol. 17, Iss. 3, pp. 217-227
Open Access | Times Cited: 28
Recent Advances in Nanomaterials for Asthma Treatment
Xu Zuo, Xiaoping Guo, Yinuo Gu, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 22, pp. 14427-14427
Open Access | Times Cited: 16
Carbonate Apatite Nanoparticles Act as Potent Vaccine Adjuvant Delivery Vehicles by Enhancing Cytokine Production Induced by Encapsulated Cytosine-Phosphate-Guanine Oligodeoxynucleotides
Hideki Takahashi, Kazuki Misato, Taiki Aoshi, et al.
Frontiers in Immunology (2018) Vol. 9
Open Access | Times Cited: 26
Nanoparticle-Based Cpg-Oligonucleotide Therapy For Treating Allergic Asthma
Brittany E. Givens, Sean M. Geary, Aliasger K. Salem
Immunotherapy (2018) Vol. 10, Iss. 7, pp. 595-604
Open Access | Times Cited: 25
Vaccines against anthrax based on recombinant protective antigen: problems and solutions
О. А. Кондакова, Nikolai A. Nikitin, Ekaterina A. Evtushenko, et al.
Expert Review of Vaccines (2019) Vol. 18, Iss. 8, pp. 813-828
Closed Access | Times Cited: 25
A niosome formulation modulates the Th1/Th2 bias immune response in mice and also provides protection against anthrax spore challenge
Himanshu Gogoi, Rajesh Mani, Rakesh Bhatnagar
International Journal of Nanomedicine (2018) Vol. Volume 13, pp. 7427-7440
Open Access | Times Cited: 19
Anthrax prevention through vaccine and post-exposure therapy
Manish Manish, Shashikala Verma, Divya Kandari, et al.
Expert Opinion on Biological Therapy (2020) Vol. 20, Iss. 12, pp. 1405-1425
Closed Access | Times Cited: 17
<p>Crystalline and Amorphous Preparation of Aluminum Hydroxide Nanoparticles Enhances Protective Antigen Domain 4 Specific Immunogenicity and Provides Protection Against Anthrax</p>
Himanshu Gogoi, Rajesh Mani, Soumya Aggarwal, et al.
International Journal of Nanomedicine (2020) Vol. Volume 15, pp. 239-252
Open Access | Times Cited: 16
Nanotechnology of inhalable vaccines for enhancing mucosal immunity
Qin Li, Yanhua Sun, Nan Gao, et al.
Drug Delivery and Translational Research (2023) Vol. 14, Iss. 3, pp. 597-620
Closed Access | Times Cited: 5
Toll‐like receptor 4 signalling regulates antibody response to adenoviral vector‐based vaccines by imprinting germinal centre quality
Ruihua Li, Ju Liu, Shipo Wu, et al.
Immunology (2018) Vol. 155, Iss. 2, pp. 251-262
Open Access | Times Cited: 12
Biodefence research two decades on: worth the investment?
Carrie M. Long, Andrea Marzi
The Lancet Infectious Diseases (2021) Vol. 21, Iss. 8, pp. e222-e233
Open Access | Times Cited: 10
Optimization, Production, and Characterization of a CpG-Oligonucleotide-Ficoll Conjugate Nanoparticle Adjuvant for Enhanced Immunogenicity of Anthrax Protective Antigen
Bob Milley, Radwan Kiwan, Gary Ott, et al.
Bioconjugate Chemistry (2016) Vol. 27, Iss. 5, pp. 1293-1304
Open Access | Times Cited: 9
Role of site-directed mutagenesis and adjuvants in the stability and potency of anthrax protective antigen
Mohammed Ali Dahhas, Mohammad A. Alsenaidy
Saudi Pharmaceutical Journal (2022) Vol. 30, Iss. 5, pp. 595-604
Open Access | Times Cited: 6
Co-Administration of Aluminium Hydroxide Nanoparticles and Protective Antigen Domain 4 Encapsulated Non-Ionic Surfactant Vesicles Show Enhanced Immune Response and Superior Protection against Anthrax
Himanshu Gogoi, Rajesh Mani, Anshu Malik, et al.
Vaccines (2020) Vol. 8, Iss. 4, pp. 571-571
Open Access | Times Cited: 8
Effects of skeletal unloading on the bone marrow antibody repertoire of tetanus toxoid and/or CpG treated C57BL/6J mice
Trisha A. Rettig, Nina C. Nishiyama, Michael J. Pecaut, et al.
Life Sciences in Space Research (2019) Vol. 22, pp. 16-28
Open Access | Times Cited: 7
Secretory System Components as Potential Prophylactic Targets for Bacterial Pathogens
Wieslaw Swietnicki
Biomolecules (2021) Vol. 11, Iss. 6, pp. 892-892
Open Access | Times Cited: 7
Polymeric Particles as Vaccine Delivery Systems
Padma Malyala, Derek T. O’Hagan
Elsevier eBooks (2017), pp. 231-248
Closed Access | Times Cited: 5
Self-conjugated protective antigen elicits strong and durable protective antibody response against anthrax
Ying Yin, Weili Yu, Yujie Li, et al.
International Journal of Biological Macromolecules (2019) Vol. 137, pp. 790-800
Closed Access | Times Cited: 2
Page 1 - Next Page

Scroll to top